Compounds > nad
Page last updated: 2024-08-17

nad and Lung Neoplasms

nad has been researched along with Lung Neoplasms in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19904 (11.43)18.7374
1990's5 (14.29)18.2507
2000's4 (11.43)29.6817
2010's10 (28.57)24.3611
2020's12 (34.29)2.80

Authors

AuthorsStudies
Li, R; Lish, SR; Xie, X; Xu, M; Xu, Z; Yu, K1
He, P; Hou, Y; Li, N; Liu, Z; Yang, Y; Zhang, X1
Boldrini, L; Bria, E; Chiappetta, M; Ciavarella, LP; Congedo, MT; Evangelista, J; Larici, A; Lococo, F; Margaritora, S; Nachira, D; Porziella, V; Sassorossi, C1
Boldrini, L; Bria, E; Cesario, A; Charles-Davies, D; Chiappetta, M; Congedo, MT; Evangelista, J; Lococo, F; Margaritora, S; Massaccesi, M; Nachira, D; Porziella, V; Sassorossi, C; Sperduti, I; Valentini, V; Vita, E1
Chen, P; Huang, P; Jiang, K; Jiang, S; Lin, J; Zhang, X; Zhao, F1
Chen, L; Chen, S; Chen, W; Fu, W; Jiang, S; Jiang, Z; Li, D; Li, X; Ma, X; Pan, Y; Wang, Q; Xing, X; Xu, C; Zhang, L; Zhou, H1
Arslan, AA; Behndig, AF; Brennan, P; Cai, Q; Chen, C; Chen, Y; Fanidi, A; Freedman, ND; Gaziano, JM; Giles, GG; Huang, WY; Johansson, M; Koh, WP; Langhammer, A; Le Marchand, L; Manjer, J; Meyer, K; Midttun, Ø; Prentice, R; Robbins, HA; Sandsveden, M; Sesso, HD; Shu, XO; Stevens, VL; Sørgjerd, EP; Ueland, PM; Ulvik, A; Visvanathan, K; Wang, Y; Weinstein, SJ; Yuan, JM; Zahed, H; Zhang, X; Zheng, W1
Adelmann, CH; Bar-Peled, L; Bardeesy, N; Carlin, A; de Groot, A; Dürr, BR; Fischer, H; Fisher, DE; Ge, M; Gohar, M; Haigis, MC; Harry, S; Hata, AN; Hayashi, M; Mostoslavsky, R; Papagiannakopoulos, T; Richter, M; Shi, L; Takahashi, M; Vijay, V; Vornbäumen, T; Wei, TY; Weiss-Sadan, T; Wolf, K; Yang, TY; Yao, CH; Zhang, J1
Bey, EA; Boatman, MA; Carter, JH; Madajewski, B; Martinez, I1
Ai, N; Chen, X; Ge, W; Hou, Y; Lu, JJ; Yu, J; Zhao, L; Zhong, B1
Chen, T; Deng, Y; Fan, Q; Gao, J; Li, M; Li, X; Li, Z; Liu, G; Sun, L; Yao, F; Zeng, Z; Zhang, Z; Zhong, C1
Krawic, C; Luczak, MW; Zhitkovich, A1
Chen, S; Feun, LG; Kandemir, H; Kuo, MT; Li, YY; Nguyen, DJM; Prince, JS; Savaraj, N; Shah, S; Wangpaichitr, M; Wu, C1
Shao, B; Tian, L; Yan, Y; Zhou, W; Zhu, B1
Adam, J; Ashworth, A; Bigot, L; Bouillaud, F; Chabanon, RM; Dorvault, N; Durand, S; Frankum, JR; Friboulet, L; Garrido, M; Krastev, DB; Kuo, MS; Lombès, A; Lord, CJ; Mardakheh, F; Morel, D; Olaussen, KA; Pierron, G; Pontoizeau, C; Postel-Vinay, S; Sarasin, A; Sauvaigo, S; Soria, JC; Souquère, S; Sourisseau, T; Touat, M1
Felding-Habermann, B; Gay, LJ; LeBoeuf, SE; Matsuno-Yagi, A; Ritland, M; Santidrian, AF; Seo, BB; Yagi, T1
Belmont, LD; DelNagro, C; Durieux, JK; Elkins, K; Jackson, PK; Kwong, M; Lee, L; Liang, X; Liederer, BM; O'Brien, T; Oeh, J; Sampath, D; Tremayne, J; Xiao, Y; Yang, LX1
Chen, L; Ma, J; Qu, C; Sun, F; Wu, J; Xu, H; Xu, S; Zheng, D1
Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, JS; Lee, SH; Nam, B; Seong, TW; Son, J1
Cheng, X; Hao, H; Li, Q; Liu, F; Liu, H; Wang, G; Wang, H; Xing, R; Ye, H; Zhao, M1
Ahn, HS; Ahn, JH; Hong, D; Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, CH; Lee, JH; Lee, JS; Lee, SH; Seong, TW1
Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J1
Beauparlant, P; Bédard, D; Bernier, C; Chan, H; Gilbert, K; Goulet, D; Gratton, MO; Lavoie, M; Roulston, A; Turcotte, E; Watson, M1
Chen, YW; Grossman, SR; Kovi, RC; Lewis, BC; Nath, B; Paliwal, S1
Björkling, F; Christensen, MK; Jäättelä, M; Jensen, PB; Nielsen, SJ; Olesen, UH; Sehested, M1
Ichikawa, T; Ishikawa, G; Yano, T1
Beall, HD; Gibson, NW; Mulcahy, RT; Ross, D; Siegel, D; Traver, RD1
Ewing, JF; Janero, DR1
Martin-Mateo, MC; Molpeceres, LM; Ramos, G1
Huang, AC; Jacobson, EL; Shieh, WM1
Begleiter, A; Fiterman, DJ; Fourie, J; Guziec, F; Guziec, L; Monterrosa, C; Oleschuk, CJ1
Comes, R; Mustea, I1
Díaz Pérez, A; González Azpeitia, J; Nuño Lopez, J; Pereda, JM; Romero López, J; Sanchidrian, P1
Biaglow, JE; Tuttle, SW; Varnes, ME1
Kurshakova, NN1

Other Studies

35 other study(ies) available for nad and Lung Neoplasms

ArticleYear
Information entropy of quantitative chemometric endogenous fluorescence improves photonic lung cancer diagnosis.
    Applied optics, 2022, Jan-10, Volume: 61, Issue:2

    Topics: Chemometrics; Entropy; Flavin-Adenine Dinucleotide; Fluorescence; Humans; Lung; Lung Neoplasms; NAD

2022
Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 100

    Topics: Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutamine; Humans; Ketones; Lung Neoplasms; Mice; Mitochondria; NAD

2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?
    Reviews on recent clinical trials, 2022, Volume: 17, Issue:2

    Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; NAD; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Treatment Outcome

2022
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.
    Lung, 2022, Volume: 200, Issue:3

    Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Retrospective Studies

2022
In Vivo Near-Infrared Fluorescence/Ratiometric Photoacoustic Duplex Imaging of Lung Cancer-Specific hNQO1.
    Analytical chemistry, 2022, Oct-11, Volume: 94, Issue:40

    Topics: Fluorescence; Fluorescent Dyes; Humans; Lung Neoplasms; NAD; Quinones

2022
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.
    Archives of toxicology, 2023, Volume: 97, Issue:2

    Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; DNA; DNA Methylation; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NADP Transhydrogenases; Sirtuin 1

2023
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium.
    Scientific reports, 2023, 01-18, Volume: 13, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Humans; Inflammation; Interferon-gamma; Kynurenine; Lung Neoplasms; NAD; Neopterin; Tryptophan

2023
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
    Cell metabolism, 2023, 03-07, Volume: 35, Issue:3

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NAD; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction

2023
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer.
    Genes, 2023, 02-28, Volume: 14, Issue:3

    Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); NADH, NADPH Oxidoreductases; Quinones

2023
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2023, Volume: 70

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Ferroptosis; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Reactive Oxygen Species; RNA, Small Interfering; Zebrafish

2023
Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway.
    International journal of biological sciences, 2023, Volume: 19, Issue:10

    Topics: Carcinoma, Non-Small-Cell Lung; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; Lung Neoplasms; Lymphatic Metastasis; NAD; Signal Transduction

2023
NAD
    Cell cycle (Georgetown, Tex.), 2021, Volume: 20, Issue:18

    Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Amino Acids, Dicarboxylic; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Hypoxia; Cell Proliferation; Cytokines; Fibroblasts; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Lung Neoplasms; NAD; Nicotinamide Phosphoribosyltransferase; Signal Transduction; Transfection

2021
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
    Oncotarget, 2017, Jul-25, Volume: 8, Issue:30

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression; Glucose; Glutamic Acid; Glutamine; Glycolysis; Heterografts; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Mice; Mitochondria; Models, Biological; NAD; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Riluzole

2017
Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
    The Journal of international medical research, 2018, Volume: 46, Issue:4

    Topics: Aged; Asian People; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Down-Regulation; Ethnicity; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lysine; Male; Middle Aged; NAD; Neoplasm Metastasis; Prognosis; RNA, Messenger; Sirtuins; Survival Analysis

2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
    The Journal of clinical investigation, 2018, 04-02, Volume: 128, Issue:4

    Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cytokines; DNA Repair; DNA-Binding Proteins; Endonucleases; Humans; Lung Neoplasms; Mice; Mice, Nude; NAD; Neoplasm Proteins; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase

2018
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.
    The Journal of clinical investigation, 2013, Volume: 123, Issue:3

    Topics: Acrylamides; Animals; Autophagy; Autophagy-Related Protein 5; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Progression; Electron Transport Complex I; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; Mice, SCID; Microtubule-Associated Proteins; Mitochondria; Multiprotein Complexes; NAD; Neoplasm Transplantation; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; Protein Transport; Proteins; Recombinant Proteins; Saccharomyces cerevisiae Proteins; TOR Serine-Threonine Kinases

2013
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
    Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:10

    Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Heterografts; Humans; Lung Neoplasms; Mice, Nude; NAD; Pentosyltransferases; Pyrazoles; Sulfones

2013
Gene expression profiling analysis of lung adenocarcinoma.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2016, Volume: 49, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Down-Regulation; Female; Gene Expression Profiling; Gene Regulatory Networks; Humans; Lung Neoplasms; Male; Microfilament Proteins; Middle Aged; Mitogen-Activated Protein Kinase 1; NAD; Protein Interaction Maps; Proto-Oncogene Proteins c-raf; Up-Regulation

2016
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Action Potentials; Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosol; Female; Gossypol; Humans; Lung Neoplasms; Malates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NAD; NADP; Neoplasm Transplantation; Oxidative Phosphorylation; Oxidoreductases Acting on CH-NH Group Donors; Phenformin; RNA, Small Interfering

2016
De-novo NAD+ synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells.
    Oncotarget, 2016, 09-20, Volume: 7, Issue:38

    Topics: A549 Cells; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Mice; Mice, Nude; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasm Transplantation; Oxidative Stress; Oxygen; Signal Transduction; Sirtuin 1; Tryptophan

2016
Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
    Experimental & molecular medicine, 2016, 11-25, Volume: 48, Issue:11

    Topics: Adenosine Triphosphate; Aldehyde Dehydrogenase; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; NAD; Protein Isoforms

2016
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
    Cell death & disease, 2016, 12-08, Volume: 7, Issue:12

    Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays

2016
Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777.
    Anti-cancer drugs, 2009, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Line, Tumor; Colonic Neoplasms; Cyanides; Cytokines; Drug Screening Assays, Antitumor; Female; Guanidines; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Multiple Myeloma; NAD; Neoplasm Proteins; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Prodrugs; Xenograft Model Antitumor Assays

2009
The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
    Cancer research, 2007, Oct-01, Volume: 67, Issue:19

    Topics: Alcohol Oxidoreductases; Cell Hypoxia; Cell Movement; Co-Repressor Proteins; Eye Proteins; Genes, Tumor Suppressor; HCT116 Cells; Humans; Lung Neoplasms; NAD; Nerve Tissue Proteins; Oxygen; Phosphatidylinositol 3-Kinases; Reading Frames; Transfection

2007
Anticancer agent CHS-828 inhibits cellular synthesis of NAD.
    Biochemical and biophysical research communications, 2008, Mar-21, Volume: 367, Issue:4

    Topics: Acrylamides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyanides; Dose-Response Relationship, Drug; Guanidines; Humans; Lung Neoplasms; NAD; Piperidines; Signal Transduction

2008
Oxidative stress as a modulating factor of pulmonary tumorigenesis in mice; comparative study on two different strains.
    Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1993, Volume: 104, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Animals; Cell Nucleus; Glycerol; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred A; Microsomes; NAD; NADP; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances

1993
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Cancer research, 1994, Jun-15, Volume: 54, Issue:12

    Topics: Aerobiosis; Animals; Antineoplastic Agents; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Chromatography, High Pressure Liquid; DNA Damage; DNA, Neoplasm; Escherichia coli; Humans; Kinetics; Lung Neoplasms; Mitomycin; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Transfection; Tumor Cells, Cultured

1994
Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator.
    Analytical biochemistry, 1995, Dec-10, Volume: 232, Issue:2

    Topics: Animals; Bacterial Proteins; Carcinoma; Cattle; Colorimetry; Enzyme Inhibitors; Humans; Isoenzymes; Lung Neoplasms; Male; Methylphenazonium Methosulfate; Microchemistry; NAD; Neoplasm Proteins; Nitroblue Tetrazolium; Organ Specificity; Oxidation-Reduction; Potassium Cyanide; Rats; Rats, Sprague-Dawley; Spectrophotometry; Superoxide Dismutase; Superoxides; Tumor Cells, Cultured

1995
Assay for erythrocyte superoxide dismutase activity in patients with lung cancer and effects on pollution and smoke trace elements.
    Biological trace element research, 1997, Volume: 60, Issue:3

    Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Environmental Pollutants; Erythrocytes; Female; Free Radicals; Humans; Lung Neoplasms; Male; Middle Aged; NAD; Neoplasm Staging; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Tobacco Smoke Pollution; Trace Elements

1997
Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis.
    Molecular and cellular biochemistry, 1999, Volume: 193, Issue:1-2

    Topics: Animals; Breast Neoplasms; Humans; Lung Neoplasms; NAD; Neoplasms; Niacin; Rats; Skin; Skin Neoplasms; Species Specificity; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1999
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:2

    Topics: Antineoplastic Agents; Benzoquinones; Biotransformation; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured

2002
The levels of NAD and NADH in blood of patients with cancer.
    Neoplasma, 1976, Volume: 23, Issue:4

    Topics: Breast Neoplasms; Female; Glucose; Humans; Lung Neoplasms; NAD; Neoplasm Metastasis; Neoplasms; Uterine Cervical Neoplasms

1976
[Study of sputum by using the SMA 12/60. Preliminary observations].
    Revista clinica espanola, 1977, Sep-15, Volume: 146, Issue:5

    Topics: Autoanalysis; Humans; L-Lactate Dehydrogenase; Lung Diseases; Lung Neoplasms; NAD; Sputum

1977
Role of cellular non-protein thiols in oxygen consumption and peroxide reduction.
    Advances in experimental medicine and biology, 1986, Volume: 200

    Topics: Cell Line; Ethylmaleimide; Humans; Kinetics; Lung Neoplasms; NAD; Oxidation-Reduction; Oxygen Consumption; Peroxides; Sulfhydryl Compounds

1986
[On changes in oxido-reductive enzymes in the course of the development of lung cancer induced by radioactive cerium].
    Voprosy onkologii, 1967, Volume: 13, Issue:8

    Topics: Animals; Bronchial Neoplasms; Cerium Isotopes; Chinchilla; Dihydrolipoamide Dehydrogenase; Electron Transport Complex IV; Lung Neoplasms; NAD; NADP; Neoplasms, Radiation-Induced; Oxidoreductases; Rabbits; Radioisotopes; Succinate Dehydrogenase

1967